DR. MARK SOUWEIDANE TAKES THE NATIONAL STAGE TO PRESENT INNOVATIONS IN SURGICAL NEUROONCOLOGY

Dr. Mark Souweidane Leads National Conversation on the Future of Pediatric Neuro0ncology 

Dr. Mark Souweidane continues to represent Weill Cornell Medicine on the national stage, underscoring the institution’s leadership in advancing innovative, life-changing approaches to pediatric brain tumor treatment. Across multiple invited speaking engagements this year, his work has been featured prominently in conversations shaping the future of neurosurgical oncology, particularly in the areas of surgical innovation, targeted therapy delivery, and overcoming the blood-brain barrier. 

At the annual meeting of the American Association of Neurological Surgeons (AANS) in San Antonio, Dr. Souweidane presented on the “next frontier of surgical neurooncology,” highlighting biologic strategies and emerging technologies designed to transform treatment for the most challenging brain tumors. A central focus of his presentation was convection-enhanced delivery (CED), a technique that enables direct, localized drug administration into brain tumors—an approach that bypasses the blood-brain barrier and opens new possibilities for precision therapy in pediatric neurooncology. 

Dr. Souweidane was also invited to serve as faculty at the 2026 CNS Tumor Complications Course in Park City, Utah, where he joined an international panel of leading neurosurgeons. Recognized for his expertise in surgical and endoscopic approaches to intraventricular brain tumors in both children and adults, he contributed to discussions on surgical technique, complication avoidance, and improving safety in highly complex neurosurgical procedures. His participation reflects longstanding national recognition of his technical leadership and his contributions to advancing standards of care in challenging tumor locations. 

Further highlighting his influence in the field, Dr. Souweidane delivered the keynote address at the inaugural White Plains Hospital CME Symposium on Neuro-Oncology, titled “A New Era: Surgery for Inoperable Brain Tumors.” Invited by former trainee and colleague Dr. Rafael Uribe, he spoke on the rapidly evolving surgical strategies that are redefining what is considered operable in brain tumor care. In introducing his mentor, Dr. Uribe described Dr. Souweidane as “a titan in the field of neurosurgery” and “a surgeon’s surgeon,” recognizing not only his technical excellence but also his humility, mentorship, and lasting impact on generations of trainees. 

As Surgeon-in-Chief of NewYork-Presbyterian Komansky Children’s Hospital and Director of Pediatric Neurosurgery at Weill Cornell Medicine, Dr. Souweidane continues to lead efforts that expand the boundaries of what is possible in pediatric brain tumor treatment. His invited lectures across premier national and institutional platforms reflect both his individual expertise and the broader strength of Weill Cornell Medicine’s neurosurgical and neurooncology programs.